Research programme: dual prostaglandin E2/prostaglandin E4 receptor agonists - Serono
Alternative Names: AS 01; AS 02; Research programme: dual EP2/EP4 receptor agonists - SeronoLatest Information Update: 12 Mar 2008
At a glance
- Originator Merck Serono
- Class Small molecules
- Mechanism of Action Dinoprostone agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 14 Sep 2005 Suspended - Preclinical for Asthma in USA (unspecified route)
- 13 Sep 2004 Preclinical trials in Asthma in USA (unspecified route)